In a recent feature on Europe 1’s La France Bouge, Cure51's CEO and co-founder Nicolas Wolikow shared compelling insights into the company’s groundbreaking approach to understanding Cancer survival.
Cure51’s mission is simple yet revolutionary: unlock the biological secrets of exceptional Cancer survivors and use that knowledge to transform future Cancer treatments.
Credit: Europe 1
Updated: April 1, 2026
